Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-03-07 @ 11:01 PM
Study NCT ID:
NCT00645905
Status:
COMPLETED
Last Update Posted:
2008-03-28
First Post:
2008-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor:
Abbott
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M02-538
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Beverly Paperiello / Director, Clinical Program Management
Old Organization:
Abbott